1. Home
  2. LABT vs OFAL Comparison

LABT vs OFAL Comparison

Compare LABT & OFAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lakewood-Amedex Biotherapeutics Inc. Common Stock

LABT

Lakewood-Amedex Biotherapeutics Inc. Common Stock

N/A

Current Price

$2.05

Market Cap

4.6M

Sector

Health Care

ML Signal

N/A

Logo OFA Group Ordinary Shares

OFAL

OFA Group Ordinary Shares

HOLD

Current Price

$1.00

Market Cap

5.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
LABT
OFAL
Founded
N/A
2013
Country
United States
United States
Employees
N/A
10
Industry
Biotechnology: Pharmaceutical Preparations
Military/Government/Technical
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.6M
5.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
LABT
OFAL
Price
$2.05
$1.00
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.1M
634.2K
Earning Date
N/A
06-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.66
$0.08
52 Week High
$6.85
$1.78

Technical Indicators

Market Signals
Indicator
LABT
OFAL
Relative Strength Index (RSI) 39.79 90.80
Support Level $1.85 $0.86
Resistance Level $2.92 N/A
Average True Range (ATR) 0.64 0.04
MACD -0.01 0.06
Stochastic Oscillator 7.51 78.09

Price Performance

Historical Comparison
LABT
OFAL

About LABT Lakewood-Amedex Biotherapeutics Inc. Common Stock

Lakewood-Amedex Biotherapeutics Inc is a clinical-stage biotechnology company developing a novel class of fast-acting, broad-spectrum antimicrobials - the Bisphosphocin class - to treat infectious diseases and reduce the threat posed by antibiotic-resistant bacterial strains, including MRSA, VRE, and others. The company's main product is Nu-3, a topically delivered antimicrobial gel in Phase 2 clinical trials for the treatment of mildly infected diabetic foot ulcers (iDFU). It is also advancing a portfolio of early-stage pipeline compounds developed from its Bisphosphocin platform targeting potential disease indications, including complicated urinary tract infection (cUTI) and pulmonary infections.

About OFAL OFA Group Ordinary Shares

OFA Group, through its subsidiary, provides architectural services, including design and fit-out services for commercial and residential buildings in Hong Kong. The design service includes both the consultation with staff and the actual design work and the company provides a specific conceptualized design with layout plans, detailed design drawings, advice relating to, among other things, budgetary consideration, optimal use of space, the materials, fittings, furniture, appliances and other items to be used to produce a preliminary design plan and quotation. Its works include installing protective materials to cover floors or walls, installing or constructing partition walls, windows, window frames, and decorative fittings, furniture or fixtures, installing plumbing systems, etc.

Share on Social Networks: